MoonLake Immunotherapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 08/14/2026 | 16.00 M | $311.54 M | 0.00% | 21.65% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 7.00 M | $136.27 M | 9.21% | 9.47% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 4.28 M | $83.34 M | 100.00% | 5.79% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 3.37 M | $65.53 M | 40.78% | 4.55% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2026 | 3.21 M | $62.41 M | -28.46% | 4.34% |
| JUPITER TOPCO LLC | 08/14/2026 | 3.09 M | $60.08 M | 100.00% | 4.17% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 2.68 M | $52.08 M | 78.33% | 3.62% |
| WEISS ASSET MANAGEMENT LP | 08/14/2026 | 2.58 M | $50.27 M | 51.13% | 3.49% |
| CITADEL ADVISORS LLC | 09/02/2026 | 1.97 M | $38.41 M | 49.04% | 2.67% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 1.72 M | $33.40 M | 52.84% | 2.32% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 1.61 M | $31.29 M | -11.27% | 2.17% |
| VIVO CAPITAL, LLC | 08/14/2026 | 1.40 M | $27.26 M | 40.00% | 1.89% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.39 M | $27.60 M | 27.37% | 1.88% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 1.16 M | $22.56 M | -15.33% | 1.57% |
| BLACKROCK, INC. | 08/07/2026 | 1.09 M | $21.32 M | 7.14% | 1.48% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.04 M | $20.28 M | -19.56% | 1.41% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 912.72 K | $17.77 M | -14.35% | 1.23% |
| GREAT POINT PARTNERS LLC | 08/14/2026 | 855.81 K | $16.66 M | 71.16% | 1.16% |
| JANE STREET GROUP, LLC | 08/14/2026 | 853.39 K | $16.62 M | 88.13% | 1.15% |
| CANDRIAM S.C.A. | 08/13/2026 | 769.77 K | $14.97 M | -5.91% | 1.04% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 751.90 K | $14.64 M | 3.74% | 1.02% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 750.78 K | $14.62 M | 970.40% | 1.02% |
| TRAILS EDGE CAPITAL PARTNERS, LP | 08/14/2026 | 750.00 K | $14.60 M | 100.00% | 1.01% |
| HRT FINANCIAL LP | 08/14/2026 | 679.24 K | $13.22 M | 39.31% | 0.92% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 643.27 K | $12.52 M | 132.42% | 0.87% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 636.19 K | $12.39 M | 10.43% | 0.86% |
| MORGAN STANLEY | 08/13/2026 | 563.60 K | $10.97 M | -8.28% | 0.76% |
| MARSHALL WACE, LLP | 08/13/2026 | 550.35 K | $10.72 M | 394.34% | 0.74% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 496.24 K | $9.66 M | 1,056.28% | 0.67% |
| ALGERT GLOBAL LLC | 08/13/2026 | 386.96 K | $7.53 M | 155.83% | 0.52% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2026 | 384.80 K | $7.49 M | 60.67% | 0.52% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 377.95 K | $7.36 M | -23.70% | 0.51% |
| CAPRICORN FUND MANAGERS LTD | 07/24/2026 | 374.87 K | $7.29 M | 100.00% | 0.51% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 358.88 K | $6.99 M | 677.06% | 0.49% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 341.54 K | $6.65 M | 42.40% | 0.46% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 336.24 K | $6.55 M | 3.15% | 0.45% |
| UBS GROUP AG | 08/13/2026 | 328.52 K | $6.40 M | 8,369.24% | 0.44% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 326.90 K | $6.36 M | 100.00% | 0.44% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 321.00 K | $6.25 M | -46.64% | 0.43% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 313.88 K | $6.11 M | 42.29% | 0.42% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 275.00 K | $5.35 M | 0.00% | 0.37% |
| JANE STREET GROUP, LLC | 08/14/2026 | 274.00 K | $5.33 M | 196.22% | 0.37% |
| CITADEL ADVISORS LLC | 09/02/2026 | 273.10 K | $5.32 M | -58.87% | 0.37% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 253.97 K | $4.94 M | 0.00% | 0.34% |
| HOLOCENE ADVISORS, LP | 08/14/2026 | 250.00 K | $4.87 M | -58.33% | 0.34% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 08/14/2026 | 250.00 K | $4.87 M | 100.00% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 247.74 K | $4.82 M | -27.44% | 0.34% |
| WALLEYE CAPITAL LLC | 08/03/2026 | 246.87 K | $4.81 M | -22.97% | 0.33% |
| J. GOLDMAN & CO LP | 08/14/2026 | 215.95 K | $4.20 M | 57.74% | 0.29% |
| Y-INTERCEPT (HONG KONG) LTD | 07/14/2026 | 215.85 K | $4.20 M | 69.84% | 0.29% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MoonLake Immunotherapeutics institutional Ownership - FAQ's
During the previous two years, 215 institutional investors and hedge funds held shares of MoonLake Immunotherapeutics. The most heavily invested institutionals were:
BVF INC/IL: 16 M
Deep Track Capital, LP: 7 M
T. Rowe Price Investment Management, Inc.: 4.28 M
D. E. Shaw & Co., Inc.: 3.37 M
Cormorant Asset Management, LP: 3.21 M
Jupiter Topco LLC: 3.09 M
99.08% of MoonLake Immunotherapeutics stock is owned by institutional investors.
Institutional investors have bought a total of 79.42 M shares in the last 24 months. This purchase volume represents approximately $1.46 B in transactions.